Arne Møller Selected Research

SPD 502

9/2013	A prospective, randomized, multicentre trial for the treatment of refractory status epilepticus; experiences from evaluating the effect of the novel drug candidate, NS1209.
4/2007	Effect of novel AMPA antagonist, NS1209, on status epilepticus. An experimental study in rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Arne Møller Research Topics

Disease

6	Gambling (Pathological Gambling) 01/2021 - 11/2010
3	Infarction (Infarctions) 01/2021 - 04/2002
3	Cognitive Dysfunction 01/2018 - 01/2013
3	Parkinson Disease (Parkinson's Disease) 01/2014 - 03/2012
2	Pain (Aches) 01/2022 - 01/2017
2	Stroke (Strokes) 01/2021 - 02/2017
2	Ischemic Stroke 01/2021 - 02/2017
2	Neuroinflammatory Diseases 12/2020 - 10/2017
2	Autism Spectrum Disorder 10/2017 - 01/2017
2	Status Epilepticus (Complex Partial Status Epilepticus) 09/2013 - 04/2007
1	Schizophrenia (Dementia Praecox) 07/2022
1	Partial Epilepsies (Epilepsy, Partial) 12/2021
1	Parkinsonian Disorders (Parkinsonism) 01/2021
1	REM Sleep Behavior Disorder 12/2020
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2018
1	Anhedonia 01/2018
1	Cerebral Cortical Thinning 10/2017
1	Hypoxia (Hypoxemia) 10/2017
1	Necrosis 02/2017
1	Autoimmune Diseases of the Nervous System 01/2016
1	Multiple Sclerosis 01/2016
1	Brain Diseases (Brain Disorder) 01/2016
1	Alzheimer Disease (Alzheimer's Disease) 01/2016
1	Disruptive, Impulse Control, and Conduct Disorders (Kleptomania) 01/2013
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 05/2012
1	Dyskinesias (Dyskinesia) 03/2012
1	Fecal Incontinence 03/2011
1	Brain Ischemia (Cerebral Ischemia) 10/2007
1	Ischemia 10/2007
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 04/2002
1	MPTP Poisoning 01/2002

Drug/Important Bio-Agent (IBA)

9	Dopamine (Intropin)FDA LinkGeneric 01/2022 - 02/2011
4	RacloprideIBA 10/2012 - 02/2011
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 03/2012
3	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 10/2007
2	Opioid Analgesics (Opioids)IBA 01/2022 - 01/2017
2	Levodopa (L Dopa)FDA LinkGeneric 01/2019 - 03/2012
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2016 - 01/2016
2	Pharmaceutical PreparationsIBA 01/2016 - 09/2013
2	SPD 502IBA 09/2013 - 04/2007
2	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 10/2007 - 04/2007
1	Glutamic Acid (Glutamate)FDA Link 07/2022
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2021
1	Ion Channels (Ion Channel)IBA 12/2021
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 01/2021
1	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021
1	Type I Tumor Necrosis Factor ReceptorsIBA 01/2021
1	Type II Tumor Necrosis Factor ReceptorsIBA 01/2021
1	Cholinergic Agents (Cholinergics)IBA 12/2020
1	AcetylcholinesteraseIBA 12/2020
1	gamma-Aminobutyric Acid (GABA)IBA 01/2019
1	SynucleinsIBA 01/2018
1	Amyloid (Amyloid Fibrils)IBA 10/2017
1	platinum oxideIBA 10/2017
1	Valproic Acid (Depakote)FDA LinkGeneric 10/2017
1	Interleukin-8 (Interleukin 8)IBA 02/2017
1	CytokinesIBA 02/2017
1	Interleukin-6 (Interleukin 6)IBA 02/2017
1	InterleukinsIBA 02/2017
1	Interleukin-2 (IL2)IBA 02/2017
1	Interleukin-10 (Interleukin 10)IBA 02/2017
1	NeuropeptidesIBA 01/2017
1	Oxytocin (Pitocin)FDA LinkGeneric 01/2017
1	Oxytocin Receptors (Oxytocin Receptor)IBA 01/2017
1	Metformin (Glucophage)FDA LinkGeneric 01/2016
1	Hormones (Hormone)IBA 01/2016
1	Pioglitazone (Actos)FDA Link 01/2016
1	IncretinsIBA 01/2016
1	Liraglutide FDA Link 01/2016
1	Serotonin (5 Hydroxytryptamine)IBA 01/2013
1	Amyloid beta-PeptidesIBA 01/2013
1	Methylphenidate (Ritalin)FDA LinkGeneric 05/2012
1	tetralinIBA 03/2012
1	Dihydroxyphenylalanine (Dopa)IBA 03/2012
1	Biological ProductsIBA 02/2011
1	Dopamine Receptors (Dopamine Receptor)IBA 11/2010
1	Oxygen (Dioxygen)IBA 10/2007
1	Neuroprotective AgentsIBA 10/2007
1	Sodium Channels (Sodium Channel)IBA 04/2007
1	NS 1231IBA 04/2002
1	Dopa DecarboxylaseIBA 01/2002

Therapy/Procedure

2	Deep Brain Stimulation 01/2014 - 01/2013
1	Analgesia 01/2022
1	Therapeutics 03/2012
1	Electrodes (Electrode) 03/2011